pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

3,447 catalysts · 3,603 8k filing · 2,256 grant · 1,191 approval · 1,000 device adverse event · 896 device 510k · 642 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×from 2025-12-30×clear all
type
  • 8k filing3,603
  • grant2,256
  • approval1,191
  • device adverse event1,000
  • device 510k896
  • device pma642
earnings
585
  • device recall420
  • recall222
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Dec 29, 2025

    50
    ›Dec 30, 2025approval242d agoNEREUS (TRADIPITANT) — FDA approvalVanda Pharmaceuticals Inc.

    Sponsor: VANDA PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 30, 2025approval242d agoCALCIUM GLUCONATE IN SODIUM CHLORIDE (CALCIUM GLUCONATE) — FDA approvalcalcium gluconate

    Sponsor: SAGENT. Form: SOLUTION. Route: INTRAVENOUS

    full page →calcium gluconate →fda approvals ↗
    ›Dec 30, 2025grant242d agoRESEARCH INST NATIONWIDE CHILDREN'S HOSP — Somatic mutations in autism spectrum disorder

    MH grant. $181,224. PI: ALISA MO

    full page →nih reporter ↗
    ›Dec 31, 2025approval241d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: SANALUZ. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: SANALUZ. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: SCINOPHARM TAIWAN. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Dec 31, 2025approval241d agoDICLOFENAC SODIUM — FDA approvalDICLOFENAC SODIUM

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DICLOFENAC SODIUM →fda approvals ↗
    ›Dec 31, 2025approval241d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

    Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL

    full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoSELENIOUS ACID — FDA approvalSELENIOUS ACID

    Sponsor: RK PHARMA. Form: SOLUTION. Route: INTRAVENOUS

    full page →SELENIOUS ACID →fda approvals ↗
    ›Dec 31, 2025approval241d agoPONSTEL (MEFENAMIC ACID) — FDA approvalAvion Pharmaceuticals LLC

    Sponsor: AVION PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 31, 2025approval241d agoTRAMADOL HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoTRAMADOL HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoATORVASTATIN CALCIUM — FDA approvalViatris Inc

    Sponsor: UMEDICA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025grant241d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Cerebral blood flow resistance mapping to identify amyloid-related imaging ab...

    AG grant. $75,520. PI: Wesley T Richerson

    full page →nih reporter ↗
    ›Dec 31, 2025grant241d agoUNIVERSITY OF WASHINGTON — Understanding the mechanisms driving emergence of atypical age-associated thy...University of Washington

    AG grant. $49,538. PI: Dante Dennis Verendia Acenas II

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Morphogen signaling feedback and dynamics in embryonic patterning

    HD grant. $49,538. PI: Alison Guyer

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Proteomic determinants of response to checkpoint blockade in malignant pleura...University of California Los Angeles

    CA grant. $407,412. PI: Bryan Michael Burt

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoVETERANS HEALTH ADMINISTRATION — Precision-Medicine Diagnostic Support in Hospitalized Veterans with Acute Kid...

    VA grant. PI: MICHAEL E. MATHENY

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoHARVARD MEDICAL SCHOOL — Forebrain Representations and Control of Sniffing

    DC grant. $82,540. PI: Byron Howard Price

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoNORTHWESTERN UNIVERSITY AT CHICAGO — DISE - A universal kill code in health and diseaseNorthwestern University

    AG grant. $457,112. PI: Marcus E. Peter

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Multiscale Modeling of Hippocampus Vulnerability to Alzheimer's Disease Neuro...University of Southern California

    AG grant. $695,789. PI: Michael Bienkowski

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF TEXAS AT AUSTIN — CFTR gene correction via targeted exon replacement

    HL grant. $41,057. PI: Jesse Buffington

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Network biomarkers for early detection of cognitive impairment using digital ...

    AG grant. $323,825. PI: Shariq Mohammed

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Taste perception of host cues in the invasive disease vector mosquito Aedes a...

    DC grant. $238,502. PI: Lisa Soyeon Baik

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoPENNSYLVANIA STATE UNIVERSITY, THE — Estimation of risk associated with zoonotic tuberculosis in South India

    AI grant. $85,563. PI: Vivek Kapur

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoIOWA CITY VA MEDICAL CENTER — Development of Automated Motility and Strabismus Evaluation for diagnosis and...

    VA grant. PI: Alina Valentina Dumitrescu

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoVA BOSTON HEALTH CARE SYSTEM — The Role of Annexin A1 Expression in Glioblastoma-Associated Astrocytes

    VA grant. PI: Brian Magne Andersen

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoVETERANS AFFAIRS MED CTR SAN FRANCISCO — The Effects of Orexin Antagonism on Fear Extinction in PTSD

    VA grant. PI: SABRA INSLICHT

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF FLORIDA — Identifying Translational Measures of Osteoarthritic Pain Between Preclinical...University of Florida

    AR grant. $44,466. PI: Kaitlin Southern

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF ROCHESTER — Selective vulnerability of fronto-insular network in aging and Alzheimer's di...University of Rochester

    AG grant. $656,829. PI: Kuan Hong Wang

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoAUGUSTA UNIVERSITY — Epigenetic mechanisms of selective vulnerability of entorhinal PV neurons in ...

    AG grant. $542,699. PI: Yun Lei

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoOHIO STATE UNIVERSITY — Uncovering the role of WFS1 deficiency in selective vulnerability in Alzheime...

    AG grant. $657,000. PI: Hongjun Fu

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF FLORIDA — Elucidating the effects of sublingual tablets containing buprenorphine on den...University of Florida

    DE grant. $47,454. PI: Kyle Vrej Kasparian

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoOSU CENTER FOR HEALTH SCIENCES — Cumulative Effect of ACEs on the Neurocircuitry of Drug Withdrawal

    GM grant. $208,403. PI: Jason A. Avery

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Investingating the mechanisms controlling Neisseria gonorrhoeae Type IV pilus...Northwestern University

    AI grant. $75,520. PI: Kathleen Nicholson

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoCASE WESTERN RESERVE UNIVERSITY — CHCHD10 in Tauopathy in AD and ADRDCase Western Reserve University

    AG grant. $431,750. PI: Tian Liu

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoUNIVERSITY OF ROCHESTER — Molecular mechanisms of TARP modulation of AMPA receptor gating.University of Rochester

    NS grant. $226,500. PI: David Malcolm MacLean

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoLOUIS STOKES CLEVELAND VA MEDICAL CENTER — Home-based Treatment of Binocular Eye Dysfunction in Veterans with Traumatic ...

    VA grant. PI: MARK F. WALKER

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoLOUIS STOKES CLEVELAND VA MEDICAL CENTER — Mapping the Fascicular Anatomy of Human Sciatic Nerve to Inform Electrode Des...

    VA grant. PI: Andrew Shoffstall

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoSTANFORD UNIVERSITY — Defining the Role of TCF21 in Adventitial Fibroblasts in AtherosclerosisStanford University

    HL grant. $82,744. PI: Andrew Thai Nguyen

    full page →nih reporter ↗
    ›Jan 1, 2026grant240d agoPENNSYLVANIA STATE UNIVERSITY, THE — Investigating Estrogen-Mediated Signaling in Binge Drinking Microcircuits of ...

    AA grant. $37,773. PI: Victoria S Nudell

    full page →nih reporter ↗
    ← prev
    page 1 of 69
    next →
    $VNDA5.3300+1.91%
    $VTRS16.94+0.53%
    $IGC0.2670+0.41%
    $AMRX17.54-2.61%
    $IGC0.2670+0.41%
    $IGC0.2670+0.41%
    $IGC0.2670+0.41%